Precision Biosciences
Open
$6.09
Prev. Close
$6.10
High
$6.14
Low
$6.08
Market Snapshot
$150.83M
-3.5
1.33
$68.7M
68
The company is headquartered in Durham, North Carolina and currently employs 68 full-time employees. The company went IPO on 2019-03-28.
The company is headquartered in Durham, North Carolina and currently employs 68 full-time employees. The company went IPO on 2019-03-28.
Recently from Cashu
Precision BioSciences Strengthens Leadership for Gene Editing Innovation and Growth
Precision BioSciences Enhances Leadership Team to Propel Gene Editing Advancements Precision BioSciences, Inc., a clinical-stage gene editing company, is poised for significant growth with the recent…
Precision BioSciences Showcases ARCUS Innovations at Upcoming Genetic Medicine Conferences
Precision BioSciences Advances Gene Editing Innovations Through Strategic Engagements Precision BioSciences, Inc., a leading clinical-stage gene editing company based in Durham, North Carolina, is set…
Precision BioSciences: Innovating Gene Editing with ARCUS® and Advancing Genetic Medicine
Precision BioSciences: Leading the Charge in Gene Editing Innovation Precision BioSciences, Inc., a clinical-stage gene editing company based in Durham, North Carolina, is at the forefront of advancin…
Precision BioSciences Advances PBGENE-HBV Gene Editing for Chronic Hepatitis B Treatment
Precision BioSciences Advances Gene Editing Therapy for Chronic Hepatitis B Precision BioSciences, Inc. is taking significant strides in the fight against chronic hepatitis B with the clinical develop…